Cardiology >
Atherosclerosis
News, opinions and meeting coverage in cardiology.
AHA: FDA Drops Clopidogrel Bomb at AHA
ORLANDO -- The FDA has issued a public health advisory warning patients and physicians that concommitant use of clopidogrel (Plavix) and omeprazole (Prilosec and Prilosec OTC) blunts the antiplatelet effect of clopidogrel, so the combination should be avoided.
Nov 17, 2009
ESC: Peto Analysis Called Short on Proof of Simvastatin/ Ezetimibe Cancer Safety
SEATTLE -- Simvastatin/ezetimibe (Vytorin) may increase the risk of cancer after all, concluded a leading American biostatistician who dismissed as prematurely reassuring an analysis by Richard Peto, Ph.D., F.R.S., that found the link with excess malignancy to be overblown.
Sep 04, 2008